A Swedish hospital recently announced that a cancer patient was saved after doctors grew him a new windpipe in the lab using a synthetic structure and the man’s own stem cells. That might have sounded like science fiction just a
The NYT has a great article today about 61 year old Diana Nyad who is planning on swimming 60 hours straight with no sleep from Cuba to Key West. It’s a trek this record-holder attempted at age 28, but failed.
Here’s an interview I did with Rick Docksai, assistant editor for THE FUTURIST. We talk about longevity and my upcoming book, 100 Plus.
Dr. Atala of Wake Forest University is one of the leaders in the field of regenerative medicine — a true hero. Here’s a recent op-ed he wrote for CNN on the topic.
This is a super-interesting post about reactions to new technology over at the the WSJ. According to Intel’s Genevieve Bell, electricity was initially opposed because some people thought it would make women and children vulnerable in their homes at night
The headline of this USA Today story is somewhat misleading, since the trachea that was created using an artificial scaffold was made with the patient’s own cells. It’s a sort of artificial/biological mix of a trachea. In any case, the
Here is an article from Reuters reporting on Aubrey de Grey’s lecture at Britain’s Royal Institution academy of science.
From Nature News: Scientists have developed a gene-repair kit that treats the blood-clotting disorder haemophilia in mice. The technique replaces genes in targeted organs without removing cells from the body, simultaneously correcting multiple mutations. It broadens the range of diseases
From Science Daily: A yet unidentified component of coffee interacts with the beverage’s caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer’s disease. A new Alzheimer’s mouse study by researchers at the University of South
According to FDA Commissioner Margaret A. Hamburg: Our goal is to regulate these products using the best possible science. Understanding nanotechnology remains a top priority within the agency’s regulatory science initiative and, in doing so, we will be prepared to